Fujimori named to lead GEMS Asia

Article

GE has shifted its executive lineup in Asia, promoting Goran Malm to president of GE Asia-Pacific and naming Yoshiaki Fujimori to assume Malm's position as president and CEO of GE Medical Systems Asia. Fujimori was previously general manager of global

GE has shifted its executive lineup in Asia, promoting Goran Malm to president of GE Asia-Pacific and naming Yoshiaki Fujimori to assume Malm's position as president and CEO of GE Medical Systems Asia. Fujimori was previously general manager of global MRI, nuclear medicine, and PET at GE Medical Systems in Milwaukee.

Malm is credited with orchestrating the expansion of GEMS in a broad geographic region that ranges from Japan to Australia to India. In his new capacity, Malm will lead GE's international activities in the Asia-Pacific region.

Fujimori credited the MRI product development group's ability to bring new systems to market as a key to his elevation. This is Fujimori's second Asian tour of duty: He was manager of business development for GE Medical Systems Asia in 1990 when he was transferred to Milwaukee as general manager of nuclear medicine. In 1992, he was named manager of CT and radiation therapy. In February 1996, the company announced his appointment as global general manager of MRI operations.

Succeeding Fujimori as general manager of global MRI is Gene Saragnese, who was transferred to Milwaukee in late 1995 as manager of MR engineering. Fujimori's managerial duties over nuclear medicine and PET in Milwaukee were delegated to Sharon Banaszewski, who was promoted to general manager of the nuclear medicine/PET group.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.